HEADLINES: • OTE: multiple tailwinds supporting the equity story (stays BUY) • PZU: very strong 3Q25 bottom line, strong beat vs. expectations, but slower revenue growth raises questions for the future POSITIVE • Allegro: 3Q25 above expectations; FY25E guidance trimmed due to slower November NEUTRAL • Cyfrowy Polsat: 3Q25 results review – adjusted EBITDA down 12% yoy, in line with the consensus NEUTRAL • Grupa Pracuj: 3Q25 results – adjusted EBITDA up 3% yoy, 2% above our forecast and 11% above ...
UNIQA continues to execute well on its 2025-2028 strategic targets, with improving non-life profitability and expanding life and health business segments. Positive trends should drive an EPS CAGR of 8.3%, on a par with Triglav Group, and above the AT&CEE average of 6.8% and we believe UNIQA is likely to upgrade its mid-term targets. The stock offers an attractive dividend yield of 6% and despite the 65% YTD return, our valuation analysis still indicates above 10% upside from current levels. We c...
HEADLINES: • Aselsan: 3Q25 results – improved margins, strong NI beat and record backlog additions POSITIVE • Coca-Cola Icecek: 3Q25 results – recovery in operating performance begins POSITIVE • Logo Yazilim: 3Q25 results – in line, except for a small NI beat • Medicover: soft 3Q25 top line, but adjusted EBITDA beats on admin costs NEUTRAL • Enea: preliminary 3Q25 EBITDA 9% above our expectations, supported by strong Supply, Generation and Distribution NEUTRAL • Solutions by STC: 3Q25 conference...
EME Equity Market – October 2025 Hungarian BUX leads in October, Türkiye and Greece lag. The MSCI EM Europe Index added 3.5% mom in EUR terms and 1.8% mom in USD terms in October. The Hungarian BUX was the top performer, adding 9.1% mom in EUR terms; followed by the Polish WIG20 (+5.9% mom) and the Romanian BET (+5.4% mom) (in EUR terms). The Czech PX was also in the green (+2.8% mom in EUR terms). The Greek ASE and the Turkish ISE30 (-1.9% mom and -1.1% mom, in EUR terms, respectively) both los...
HEADLINES: • Hidroelectrica: water should yield more (SELL - transfer of coverage) • MONETA Money Bank: posts solid 3Q25 results NEUTRAL • Orange Polska: 3Q25 results – EBITDAaL up 4% yoy, 2% above the consensus; 2025E guidance reiterated POSITIVE • Kety: full 3Q25 results fully in line with the preliminaries NEUTRAL • Sarantis: 3Q trading update slightly below expectations; FY25E guidance maintained NEGATIVE • MOL: to become a holding company NEUTRAL • Warsaw Stock Exchange: CEO favours Poland ...
PZU continues to execute well on its 2025-2027 strategic targets, with improving non-life profitability and expanding life and health business segments. Positive trends should drive the EPS growth of 5.7% CAGR, just below the AT&CEE average. The stock offers the highest DY in our sector coverage (8%+) and a superior ROE within the AT&CEE peer group. Our valuation analysis indicates 19% upside from current levels and triggers an upgrade of our rating to Outperform.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.